See more : CviLux Corporation (8103.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Aedifica SA (AEDFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aedifica SA, a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Nabors Energy Transition Corp. II Warrant (NETDW) Income Statement Analysis – Financial Results
- ATOME Energy PLC (ATOM.L) Income Statement Analysis – Financial Results
- Nikko Co., Ltd. (6306.T) Income Statement Analysis – Financial Results
- Jade Art Group Inc. (JADA) Income Statement Analysis – Financial Results
- Sixty North Gold Mining Ltd. (SXTY.CN) Income Statement Analysis – Financial Results
Aedifica SA (AEDFF)
About Aedifica SA
Aedifica is a Belgian listed company that offers sustainable real estate solutions to professional operators that provide care to people with care needs throughout Europe. To realise that mission, Aedifica has specialised in investments in quality European healthcare real estate, with a particular focus on the care needs of the elderly. Aedifica has established itself in recent years as a leader in the European listed real estate sector and has the ambition to further expand this position in the coming years. By investing in quality buildings that generate recurring and indexed rental income and offer potential for capital gains, Aedifica aims to offer its shareholders a reliable and sustainable real estate investment with an attractive yield. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019). Since March 2020, Aedifica is part of the BEL 20, the leading share index of Euronext Brussels.
| Metric | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 321.11M | 277.07M | 236.36M | 178.59M | 121.22M | 94.23M | 81.61M | 61.91M | 51.75M | 41.81M | 37.42M | 35.20M | 28.86M | 23.31M | 23.05M | 20.28M | 12.92M | 2.85M |
| Cost of Revenue | 19.65M | 9.75M | 7.93M | 10.25M | 6.22M | 6.33M | 5.99M | 6.04M | 6.21M | 4.95M | 5.01M | 4.56M | 36.00K | 83.00K | 107.00K | 2.33M | 1.56M | 289.00K |
| Gross Profit | 301.47M | 267.32M | 228.43M | 168.34M | 115.01M | 87.90M | 75.62M | 55.87M | 45.53M | 36.86M | 32.41M | 30.65M | 28.82M | 23.22M | 22.94M | 17.95M | 11.36M | 2.56M |
| Gross Profit Ratio | 93.88% | 96.48% | 96.65% | 94.26% | 94.87% | 93.28% | 92.66% | 90.24% | 87.99% | 88.16% | 86.61% | 87.05% | 99.88% | 99.64% | 99.54% | 88.53% | 87.91% | 89.86% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 33.57M | 10.97M | 9.40M | 24.06M | 5.25M | 2.71M | 2.32M | 2.25M | 1.97M | 1.57M | 1.42M | 1.26M | 0.00 | 0.00 | 560.00K | 0.00 | 2.69M | 1.16M |
| Selling & Marketing | 720.00K | 1.03M | 656.00K | 156.00K | 454.00K | 547.00K | 432.00K | 530.00K | 485.00K | 384.00K | 341.00K | 328.00K | 548.00K | 0.00 | 0.00 | 567.00K | 380.00K | 65.00K |
| SG&A | 34.29M | 11.99M | 10.05M | 24.22M | 5.71M | 3.25M | 2.76M | 2.78M | 2.46M | 1.95M | 1.76M | 1.59M | 548.00K | 0.00 | 560.00K | 567.00K | 3.07M | 1.22M |
| Other Expenses | 171.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 206.48M | 37.64M | 35.11M | 20.08M | 17.86M | 10.63M | 9.84M | 8.25M | 6.51M | 5.44M | 4.88M | 4.48M | 7.13M | 6.20M | 6.62M | 4.95M | 4.61M | 1.96M |
| Cost & Expenses | 225.87M | 47.39M | 43.04M | 30.33M | 24.08M | 16.96M | 15.83M | 14.30M | 12.72M | 10.39M | 9.89M | 9.03M | 7.17M | 6.28M | 6.73M | 7.28M | 6.17M | 2.24M |
| Interest Income | 2.18M | 1.18M | 327.00K | 15.08M | 28.00K | 15.00K | 71.00K | 59.00K | 31.00K | 100.00K | 87.00K | 257.00K | 104.00K | -5.29M | -7.57M | 421.00K | 240.00K | 52.00K |
| Interest Expense | 72.63M | 25.10M | 18.60M | 0.00 | 10.17M | 8.73M | 8.38M | 5.21M | 6.08M | 4.26M | 3.49M | 6.00M | 9.13M | 7.61M | 7.87M | 6.34M | 2.90M | 1.14M |
| Depreciation & Amortization | 3.65M | 3.49M | 1.66M | 780.67K | 651.00K | 804.00K | 678.00K | 701.00K | 670.00K | 599.00K | 553.00K | 484.00K | 381.00K | 355.00K | 319.00K | 287.00K | 265.00K | 139.00K |
| EBITDA | 73.21M | 235.33M | 360.49M | 144.91M | 98.93M | 76.08M | 66.46M | 48.32M | 39.69M | 32.02M | 28.09M | 36.07M | 30.04M | 10.82M | -654.00K | 21.15M | 9.09M | 1.12M |
| EBITDA Ratio | 22.80% | 107.30% | 149.75% | 81.14% | 137.42% | 98.21% | 94.47% | 95.33% | 114.14% | 86.11% | 97.93% | 102.47% | 120.99% | 46.43% | -2.84% | 104.98% | 70.39% | 39.91% |
| Operating Income | 95.25M | 297.24M | 350.53M | 144.13M | 167.78M | 92.74M | 77.59M | 59.12M | 58.71M | 35.24M | 36.60M | 35.65M | 30.52M | 15.76M | 6.59M | 19.13M | 9.02M | 1.04M |
| Operating Income Ratio | 29.66% | 107.28% | 148.30% | 80.70% | 138.41% | 98.42% | 95.08% | 95.49% | 113.46% | 84.28% | 97.81% | 101.26% | 105.75% | 67.62% | 28.61% | 94.34% | 69.87% | 36.61% |
| Total Other Income/Expenses | -98.31M | 89.17M | -10.98M | -24.23M | -26.34M | -17.48M | -11.42M | -18.39M | -12.77M | -13.96M | -8.86M | -20.26M | -5.12M | -12.91M | -15.44M | -4.47M | -2.79M | -1.20M |
| Income Before Tax | -3.07M | 386.41M | 339.55M | 133.18M | 141.44M | 75.26M | 66.17M | 40.73M | 45.94M | 21.28M | 27.74M | 15.39M | 25.40M | 2.85M | -8.85M | 14.66M | 6.24M | -161.00K |
| Income Before Tax Ratio | -0.96% | 139.46% | 143.66% | 74.57% | 116.68% | 79.87% | 81.08% | 65.78% | 88.77% | 50.91% | 74.13% | 43.72% | 88.02% | 12.25% | -38.37% | 72.29% | 48.30% | -5.65% |
| Income Tax Expense | -25.62M | 54.68M | 56.73M | 17.56M | 10.71M | 3.41M | 2.82M | 461.00K | 771.00K | -103.00K | 70.00K | 54.00K | 80.00K | 64.00K | 48.00K | 54.00K | 29.00K | 61.00K |
| Net Income | 24.54M | 331.78M | 281.82M | 115.38M | 103.89M | 71.86M | 63.36M | 40.27M | 45.17M | 21.39M | 27.67M | 15.34M | 25.32M | 2.79M | -8.89M | 14.61M | 6.21M | -222.00K |
| Net Income Ratio | 7.64% | 119.75% | 119.23% | 64.60% | 85.70% | 76.25% | 77.63% | 65.04% | 87.28% | 51.15% | 73.95% | 43.57% | 87.75% | 11.97% | -38.58% | 72.03% | 48.07% | -7.79% |
| EPS | 0.56 | 8.51 | 7.91 | 4.35 | 3.60 | 3.80 | 3.80 | 2.60 | 3.77 | 1.92 | 2.58 | 1.74 | 3.01 | 0.46 | -1.43 | 2.41 | 1.39 | -0.23 |
| EPS Diluted | 0.56 | 8.51 | 7.91 | 4.35 | 3.60 | 3.80 | 3.80 | 2.60 | 3.77 | 1.92 | 2.58 | 1.74 | 3.01 | 0.46 | -1.43 | 2.41 | 1.39 | -0.23 |
| Weighted Avg Shares Out | 43.71M | 38.11M | 35.61M | 26.54M | 28.84M | 18.89M | 16.68M | 15.46M | 12.00M | 11.17M | 10.72M | 8.80M | 8.41M | 6.03M | 6.24M | 6.04M | 4.48M | 946.57K |
| Weighted Avg Shares Out (Dil) | 43.71M | 39.01M | 35.61M | 26.54M | 28.84M | 18.89M | 16.68M | 15.46M | 12.00M | 11.17M | 10.72M | 8.80M | 8.41M | 6.03M | 6.24M | 6.04M | 4.48M | 946.57K |
Aedifica NV/SA: Repurchase of own shares
Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding a repurchase of own shares.
Aedifica NV/SA: Interim financial report – Q3 2024
Please find below Aedifica's interim financial report for the 3rd quarter of the 2024 financial year. Robust operational performance driving strong results above budget EPRA Earnings* amounted to €178.3 million (+7% compared to 30 Sept.
Aedifica NV/SA: Publication relating to a transparency notification
Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding a publication relating to a transparency notification.
Aedifica: Healthcare REIT Offers A 6.45% Yield With An 80% Payout Ratio
Aedifica, a Belgian REIT, focuses on healthcare real estate, with robust earnings due to low fixed-rate debt and a healthy dividend yield of 6.45%. Despite potential dividend tax increases and rising debt costs, Aedifica's earnings are expected to remain stable...
Aedifica NV/SA: 2024 half year financial report
Please find below Aedifica's 2024 half year financial report. Robust operational performance driving strong results above budget EPRA Earnings* amounted to €118.8 million (+8% compared to 30 June 2023), or €2.50/share Rental income increased to €165.8 million (+7% compared to...
Aedifica NV/SA: Interim financial report – Q1 2024
Please find below Aedifica's interim financial report for the 1st quarter of the 2024 financial year. Robust operational performance driving strong results ahead of budget EPRA Earnings* amounted to €59.8 million (+8% compared to 31 March 2023), or €1.26/share Rental...
Aedifica NV/SA: Repurchase of own shares
Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding a repurchase of own shares.
Aedifica NV/SA: 2023 Annual Report
Download Aedifica's 2023 Annual Report by clicking on the link below. Attachments Annual Report (EN) Rapport Annuel (FR) Jaarverslag (NL)
Aedifica NV/SA: Convocation to the Extraordinary General Meeting and Ordinary General Meeting of 14 May 2024
Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the Extraordinary General Meeting and Ordinary General Meeting of Tuesday 14 May 2024.
Aedifica: A 7.3% Yield From A Triple Net Lease REIT
Aedifica is a Belgian REIT focused on healthcare real estate, particularly nursing homes and facilities for the aging population. The company is active in multiple countries, with Germany, Belgium, the UK, and Finland each accounting for approximately 20% of its...
Source: https://incomestatements.info
Category: Stock Reports